跳至主要内容
临床试验/NCT01796145
NCT01796145进行中(未招募)不适用

A Study to Evaluate the Impact of Liver Stiffness on Treatment Outcome of Hepatocellular Carcinoma

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2013年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
207
试验地点
1
主要终点
Overall survival

研究概览

简要总结

In patients with HCC undergoing therapy 1. We aim to determine the prognostic significance of liver stiffness in patients with HCC 2. We aim to determine the rate and severity of complications of treatment and its association with liver stiffness in patients with HCC

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of HCC
  • Patients who are scheduled to undergo therapy, either TACE systemic therapy or surgery
  • For TACE cohort, patients undergoing first cycle TACE are eligible.
  • For systemic therapy cohort, patients undergoing first-line systemic therapy are eligible.
  • For surgery cohort, patient undergoing surgery are eligible.
  • Prior surgery or loco-ablative therapy (e.g. Radiofrequency ablation, microwave, percutaneous ethanol injection) is allowed
  • Child's A to Child's C liver function

排除标准

  • ECOG performance status > 2
  • Poorly controlled ascites

结局指标

主要结局

Overall survival

时间窗: 3 years

次要结局

  • Liver stiffness (kPa)(2 years)
  • Rate and grade of treatment complications(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

CCTU

Comprehensive Cancer Trials Unit

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验